Biologic medicines, or protein-based medicines such as insulin, are designed to interact with specific targets in the patient’s body. A more targeted mechanism of action should lead to a...
Small populations present ethical and practical challenges to organising clinical trials. Small populations include groups with rare diseases or specific sub-types of common diseases, children, and the elderly.
Clinical trial results are statistically analysed in terms of demographics, efficacy, and safety. Different types of clinical trial may warrant different interpretations of trial results.
Generic medicines are copies of original, branded medicines. They can be manufactured and sold after the protection on an original product expires. They have the same form and active...
An example of patients involved through patients and patient organisations providing input into a
Cushing’s disease clinical trial design. The consultation took place between Novartis and nurses from different teams...
A collaboration between Bristol-Myers Squibb (BMS) with FUNDHEPA (patient organisation) to give more patients the opportunity to receive an innovative treatment for Hepatitis C through the participation in a...
It is important to have information reachable for patient's organisations, so they can publish it using their tools and making it more accessible for patients.
